Neuropsychiatric symptoms and expenditure on complementary and alternative medicine

Journal of Clinical Psychiatry

Volumn 76, Issue 7, 2015, Pages e870-e876

  Purohit, Maulik P ^a,b,c,d,e   Zafonte, Ross D ^a,b,d   Sherman, Laura M ^a   Davis, Roger B ^c   Giwerc, Michelle Y ^d   Shenton, Martha E ^d   Yeh, Gloria Y ^c  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e FORT BELVOIR COMMUNITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; AMNESIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HEADACHE; HEALTH CARE COST; HUMAN; INCOME; INSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MEDICAL HISTORY; MENTAL DISEASE; NEUROPSYCHIATRIC SYMPTOM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SLEEP DISORDER; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISORDERS OF EXCESSIVE SOMNOLENCE; ECONOMICS; MEMORY DISORDERS; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLEMENTARY THERAPIES; DEPRESSION; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HEADACHE; HEALTH EXPENDITURES; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 84938149376     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08682     Document Type: Article

References (38)

1. Purohit MP, Wells RE, Zafonte RD, et al. Neuropsychiatric symptoms and the use of complementary and alternative medicine. PM R. 2013;5(1):24-31. doi:10.016/pmrj.21206.012 PubMed
2. Purohit MP, Wells RE, Zafonte RD, et al. Neuropsychiatric symptoms and the use of mind-body therapies. J Clin Psychiatry. 2013;74(6):e520-e526. doi:10.408/JCP.12m08246 PubMed
3. Vaishnavi S, Rao V, Fann JR. Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic. Psychosomatics. 2009;50(3):198-205. doi:10.176/ai.psy503.198 PubMed
4. Hetrick SE, Purcell R, Garner B, et al. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010;7(7): CD007316. PubMed
5. Roth RS, Geisser ME, Theisen-Goodvich M, et al. Cognitive complaints are associated with depression, fatigue, female sex, and pain catastrophizing in patients with chronic pain. Arch Phys Med Rehabil. 2005;86(6):1147-1154. doi:10.1016/j.apmr.201.041 PubMed
6. Grandner MA, Jackson NJ, Pak VM, et al. Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res. 2012;21(4): 427-433. PubMed
7. Plantinga L, Rao MN, Schillinger D. Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005-2008. Prev Chronic Dis. 2012;9:E76. PubMed
8. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical imp lic ati ons. Lancet Neurol. 2012;11(1):92-100. doi:10.06/S17-422(1)702-6 PubMed
9. Schürks M, Rist PM, Shapiro RE, et al. Migraine and mortality: a systematic review and meta-analysis. Ceph alalgia. 2011;31(12):1301-1314. doi:10.117/0330241415879 PubMed
10. Shahly V, Berglund PA, Coulouvrat C, et al. The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry. 2012; 69 (10):1054-1063. doi:10.01/archgenpsychiatry201.218 PubMed
11. NIH definition of CAM. http://nccam.nih.gov/health/whatiscam. Updated July 2014. Accessed April 11, 2015.
12. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;10(12):1-23. PubMed
13. Gross CR, Kreitzer MJ, Reilly-Spong M, et al. Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. E xplore (NY). 2011;7(2):76-87. doi:10.016/j.explore20.12.03 PubMed
14. Joo HM, Lee SJ, Chung YG, et al. Effects of mindfulness based stress reduction program on depression, anxiety and stress in patients with aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc. 2010; 47(5): 345-351. doi:10.340/jkns.2010475.345PubMed
15. Vøllestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther. 2011;49(4):281-288. doi:10.016/jbrat.201. 07 PubMed
16. Chiesa A, Mandelli L, Serretti A. Mindfulness-based cognitive therapy versus psycho-education for patients with major depression who did not achieve remission following antidepressant treatment: a preliminary analysis. J Altern Complement Med. 2012;18(8):756-760. doi:10.1089/acm21.0407 PubMed
17. Hoge EA, Bui E, Marques L, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013;74(8):786-792. doi:10.4088/JCP.12m083 PubMed
18. Zollman FS, Larson EB, Wasek-Throm LK, et al. Acupuncture for treatment of insomnia in patients with traumatic brain injury: a pilot intervention study. J Head Trauma Rehabil. 2012; 27(2):135-142. PubMed
19. Hölzel BK, Carmody J, Vangel M, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res. 2011;191(1):36-43. doi:10.016/j.psychrens.2018.06 PubMed
20. Hölzel BK, Ott U, Gard T, et al. Investigation of mindfulness meditation practitioners with voxel-based morphometry. Soc Cogn Affect Neurosci. 2008;3(1):55-61. doi:10.1093sca/nsm038 PubMed
21. Hölzel BK, Carmody J, Evans KC, et al. Stress reduction correlates with structural changes in the amygdala. Soc Cogn Affect Neurosci. 2010;5(1):11-17. doi:10.1093/sca/nsp034 PubMed
22. Hölzel BK, Ott U, Hempel H, et al. Differential engagement of anterior cingulate and adjacent medial frontal cortex in adept meditators and non-meditators. Neurosci Lett. 2007; 421(1):16-21. doi:10.016/j.nulet27.04.074 PubMed
23. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport. 2005;16 (17):1893-1897. doi:10.1097/01.wnr.018598.6243.19 PubMed
24. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med. 2007;13(4):419-426. doi:10.1089/acm.207.6338PubMed
25. Graham RE, Gandhi TK, Borus J, et al. Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care advances in patient safety: new directions and alternative approaches. In: Henriksen K, Battles JB, Keyes MA, et al, eds. Advances in Patient Safety: New Directions and Alternative Approaches (Vol 4: Technology and Medication Safety). Rockville MD: Agency for Healthcare Research and Quality (US); 2008.
26. Snitz BE, O'Meara ES, Carlson MC, et al; Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009;302(24):2663-2670. doi:10.01/jma.200.913 PubMed
27. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292(23): 2868-2873. doi:10.01/jama.923.2868 PubMed
28. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US-and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-923. doi:10.01/jma.308.915 PubMed
29. Zafonte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308(19):1993-2000. doi:10.1001/jama02.13256 PubMed
30. NHIS 2007 survey description document. f tp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Dataset-Documentation/NHIS/2007/srvydesc. pdf. Updated June 2008. Accessed April 11, 2015.
31. National Health Interview Survey. 2007. http://www.cdc.gov/NCHS/nhis/nhis-2007-data- release.htm. Updated December 14, 2012. Accessed April 11, 2015.
32. Otis JD, McGlinchey R, Vasterling JJ, et al. Complicating factors associated with mild traumatic brain injury: impact on pain and posttraumatic stress disorder treatment. J Clin Psychol Med Settings. 2011;18(2):145-154. doi:10.107/s10801-939-2 PubMed
33. Aznar S, Knudsen GM. Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? J Alzheimers Dis. 2011; 23 (2):177-193. PubMed
34. Erwin Wells R, Phillips RS, McCarthy EP. Patterns of mind-body therapies in adults with common neurological conditions. Neuroepidemiology. 2011; 36 (1): 46-51. doi:10.159/032249PubMed
35. Wells RE, Phillips RS, Schachter SC, et al. Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol. 2010;257(11):1822-1831. doi:10.107/s04110-516-2 PubMed
36. Carlson MJ, Krahn G. Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey. Disabil Rehabil. 2006;28(8):505-513. doi:10.1080/09638285021062 PubMed
37. National health expenditures. https://www. cms.gov/NationalHealthExpendData/downloads/tables.pdf. Updated 2008. Accessed April 11, 2015.
38. Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ. 2012;13(6):769-776. doi:10.107/s198-01-30-2